NORRIS MEDICINES LTD.
BSE: 524414
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|---|---|
| INCOME | ||||||
| Revenue | 3.27+124.3% | 1.46-46.5% | 2.72+146.0% | 1.11-12.8% | 1.27+74.9% | 0.72 |
| Other Income | 0.00-99.6% | 0.02-47.5% | 0.05+1410.0% | 0.00+200.0% | 0.00-91.7% | 0.01 |
| Total Income | 3.27+120.7% | 1.48-46.5% | 2.77+149.4% | 1.11-12.7% | 1.27+72.3% | 0.74 |
| EXPENSES | ||||||
| Expenditure | 2.57+43.5% | 1.79-39.0% | 2.94+111.0% | 1.39-14.7% | 1.63+47.9% | 1.10 |
| Tax | 0.00 | 0.00-100.0% | 0.06 | — | — | — |
| PROFIT | ||||||
| PBT | 0.70+324.7% | -0.31-83.6% | -0.17+40.0% | -0.28+21.9% | -0.36+1.4% | -0.37 |
| Net Profit | 0.70+324.7% | -0.31-35.8% | -0.23+19.0% | -0.28+21.9% | -0.36+1.4% | -0.37 |
| KEY METRICS | ||||||
| OPM % | 28.95%+35.83pp | -6.88%-9.47pp | 2.59%+51.69pp | -49.10%-3.36pp | -45.74%+36.33pp | -82.07% |
| NPM % | 21.35%+42.32pp | -20.97%-12.71pp | -8.26%+17.17pp | -25.43%+3.00pp | -28.43%+21.23pp | -49.66% |
| EPS | 0.70+125.8% | 0.31+34.8% | 0.23+182.1% | -0.28+22.2% | -0.36+2.7% | -0.37 |
Corporate Events
Board MeetingNORRIS
202630May
Board Meeting
To consider and approve Audited Financial Results for the qu…
BSE Filing ↗ Board MeetingNORRIS
202414Nov
Board Meeting
consider and approve Un-audited Financial Results for the qu…
BSE Filing ↗ Board MeetingNORRIS
202414Aug
Board Meeting
To consider and approve Un-audited Financial Results for the…
BSE Filing ↗ Board MeetingNORRIS
202429May
Board Meeting
Approval of Standalone Audited Financial Results and Stateme…
BSE Filing ↗